Embecta makes pen needles, insulin syringes and safety injection devices for people with diabetes. It last closed at $6.02 on Nov 20, down 2.75% on the day. The next earnings report for EMBC is expected around Tue, Nov 24, 2026. For the quarter ended Jun 2026, EMBC reported EPS of $0.36 on revenue of $271.7M, with revenue down 8.1% from a year ago. Over its last 8 reports the stock moved an average of 20.0% the session after earnings. Over the last 12 months EMBC insiders bought $558K of stock on the open market and sold $37K, according to SEC Form 4 filings.
AI Auto Pilots
Is EMBC in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold EMBC.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on EMBCStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
EMBC · as of the Nov 20 close · updated each morning
Downtrend
The stock is 5% below its 20 day and 1% below its 50 day average. It is sitting right on its 200 day average, a level many traders watch. Momentum is weak (RSI 44). The nearest support is the Pivot S1 at $5.81, and the nearest resistance the 200 day average at $6.06.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityHigh, 5.6%/day
Key levels
$14.8052 week high+145.8%
$6.3420 day average+5.3%
$6.31Pivot R1+4.8%
$6.16Swing high (Oct 7)+2.3%
$6.11Pivot+1.5%
$6.0650 day average+0.7%
$6.06200 day average+0.7%
$6.02Last close
$5.81Pivot S1−3.5%
$5.78Swing low (Nov 6)−4.0%
$5.16100 day average−14.3%
$2.7752 week low−54.0%
Indicators
RSI (14)
44.24
Middle of its range
Neutral
MACD
0.01
Below its signal line
Bearish
Stochastic
31.7
Middle of its range
Neutral
ADX (14)
17.1
No clear trend
Williams %R
-76.2
Oversold below −80, overbought above −20
Neutral
CCI (20)
-103.0
Oversold below −100, overbought above 100
Oversold
Rate of change
−2.8%
Change over 10 sessions
Bearish
ATR (14)
$0.34
Typical daily range, 5.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Below
Bounce inside a longer downtrend
Short trendBullish
Long trendBearish
MomentumImproving
StretchNormal
VolatilityNormal, 12.6%/day
Key levels
$14.8052 week high+145.8%
$6.3420 day average+5.3%
$6.31Pivot R1+4.8%
$6.16Swing high (Oct 7)+2.3%
$6.11Pivot+1.5%
$6.0650 day average+0.7%
$6.06200 day average+0.7%
$6.02Last close
$5.81Pivot S1−3.5%
$5.78Swing low (Nov 6)−4.0%
$5.16100 day average−14.3%
$2.7752 week low−54.0%
Indicators
RSI (14)
50.83
Middle of its range
Neutral
MACD
-0.01
Above its signal line
Bullish
Stochastic
73.7
Middle of its range
Neutral
ADX (14)
22.4
Weak trend
Williams %R
-41.9
Oversold below −80, overbought above −20
Neutral
CCI (20)
69.9
Oversold below −100, overbought above 100
Neutral
Rate of change
+21.9%
Change over 10 sessions
Bullish
ATR (14)
$0.76
Typical daily range, 12.6% of price
MA 10Below
MA 20Above
MA 50Below
MA 100Below
MA 200Below
What happened before, for EMBC
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how EMBC did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow EMBC usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for EMBCHow many large options trades hit EMBC, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in EMBC in the last 90 days.
From SEC Form 4 filings by EMBC's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether EMBC is in one of them and how their past EMBC trades turned out.
Embecta is a medical device company focused on helping people with diabetes manage insulin injections. Its main products are pen needles, insulin syringes and safety injection devices, which are designed to work with insulin pens and vials and to help protect users and healthcare workers from needlestick injuries. The company sells to patients, retailers, hospitals, pharmacies and other healthcare providers in many countries. It is based in Parsippany, New Jersey.